PAHC

Peers: ELAN ZTS NEOG BCPC MRK ODC IDXX DAR ADM BG

| Held by: IJR VTI IWM VXF IWO SPSM IJT DFAS XPH SLYG

Index	RUT
Market Cap	1.52B
Enterprise Value	2.23B
Income	99.72M
Sales	1.52B
Book/sh	9.50
Cash/sh	2.02
Dividend Est.	0.48 (1.28%)
Dividend TTM	0.48 (1.28%)
Dividend Ex-Date	Sep 02, 2026
Dividend Gr. 3/5Y	0.00% 0.00%
Payout	19.72%
Employees	2605
IPO	Apr 11, 2014

P/E	15.37
Forward P/E	9.72
PEG	1.15
P/S	1.00
P/B	3.94
P/C	18.53
P/FCF	153.89
EV/EBITDA	8.82
EV/Sales	1.47
Quick Ratio	1.27
Current Ratio	2.96
Debt/Eq	2.05
LT Debt/Eq	1.95
Option/Short	Yes / Yes

EPS (ttm)	2.43
EPS next Y	3.85
EPS next Q	0.78
EPS this Y	8.60%
EPS next Y	10.07%
EPS next 5Y	8.47%
EPS past 3/5Y	44.61% 12.64%
Sales past 3/5Y	15.79% 12.74%
EPS Y/Y TTM	106.40%
Sales Y/Y TTM	17.12%
EPS Q/Q	25.12%
Sales Q/Q	4.77%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	19.25% 4.07%

Insider Own	48.48%
Insider Trans	-0.04%
Inst Own	52.21%
Inst Trans	0.10%
ROA	6.97%
ROE	29.72%
ROIC	8.76%
Gross Margin	33.61%
Oper. Margin	13.23%
Profit Margin	6.57%
SMA20	-2.52%
SMA50	0.88%
SMA200	-9.28%
Trades

Shs Outstand	21.07M
Shs Float	20.92M
Short Float	4.94%
Short Ratio	4.69
Short Interest	1.03M
52W High	60.08 -37.73%
52W Low	28.25 32.43%
Volatility	3.41% 3.63%
ATR (14)	1.45
RSI (14)	47.09
Beta	0.41
Rel Volume	0.80
Avg Volume	220.27K
Volume	151,117

Perf Week	-2.53%
Perf Month	0.59%
Perf Quarter	3.89%
Perf Half Y	-33.48%
Perf YTD	0.14%
Perf Year	-13.74%
Perf 3Y	203.17%
Perf 5Y	67.99%
Perf 10Y	43.61%
Recom	2.33
Target Price	47.00
Prev Close	38.74
Price	37.41
Change %	-3.43%

Consensus

Buy

Avg. Price Target

$47.00

Implied Upside

+25.6%

Analysts11incl. previous ratings

Rating Distribution2 Buy · 6 Hold · 3 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Apr 15, 2026	Initiated	CCitigroup	Neutral	$62	+65.7%
Jul 07, 2025	Upgrade	JJP Morgan	Neutral → Overweight	$35	-6.4%
Jun 16, 2025	Upgrade	BBNP Paribas Exane	Underperform → Neutral	$24	-35.8%
Sep 10, 2024	Initiated	JJP Morgan	Neutral	$22	-41.2%
Dec 07, 2023	Initiated	EExane BNP Paribas	Underperform	$9	-75.9%
Dec 21, 2022	Initiated	RROTH Capital	Buy	$18	-51.9%
Jul 25, 2022	Downgrade	BBarclays	Equal Weight → Underweight	$22	-41.2%
Jan 10, 2022	Upgrade	BBarclays	Underweight → Equal Weight	$23	-38.5%
Nov 18, 2021	Initiated	MMorgan Stanley	Equal-Weight	$23	-38.5%
Aug 05, 2021	Resumed	CCredit Suisse	Neutral	$25	-33.2%
Jul 07, 2021	Downgrade	BBarclays	Equal Weight → Underweight	$23	-38.5%
Aug 06, 2020	Downgrade	MMorgan Stanley	Equal-Weight → Underweight	$20	-46.5%
Feb 06, 2020	Downgrade	GGabelli & Co	Buy → Hold	$30	-19.8%
Jan 28, 2020	Upgrade	BBarclays	Underweight → Equal Weight
Sep 05, 2019	Upgrade	MMorgan Stanley	Underweight → Equal-Weight	$21 → $30	-19.8%
Aug 29, 2019	Reiterated	BBofA/Merrill	Underperform	$29 → $18	-51.9%
Jun 11, 2019	Initiated	BBarclays	Underweight	$25	-33.2%
May 23, 2019	Initiated	GGuggenheim	Neutral
May 09, 2019	Upgrade	GGabelli & Co	Hold → Buy	$42	+12.3%
Aug 23, 2017	Resumed	BBofA/Merrill	Underperform	$33	-11.8%

Oct-28-26 09:49PM	Phibro's Street Estimates Sit Above Its Own Outlook As Brazil Decision Looms (Earnings Whispers)
04:30PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results (Business Wire)
Sep-09-26 04:30PM	Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference (Business Wire)
Aug-27-26 05:06PM	Phibro Animal Health Corp (PAHC) (Q4 2026) Earnings Call Highlights: Record Sales and Strategic ... (GuruFocus.com)
Aug-26-26 04:35PM	Phibro: Fiscal Q4 Earnings Snapshot (Associated Press)
04:20PM	Loading…
04:20PM	Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance (Business Wire)
Aug-19-26 04:30PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results (Business Wire)
Jul-28-26 04:10PM	Phibro Animal Health Corporation Declares Quarterly Dividend (Business Wire)
May-21-26 04:30PM	Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference (Business Wire)
May-07-26 04:30PM	Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference (Business Wire) -26.22% -7.32%
May-06-26 05:26PM	Phibro: Fiscal Q3 Earnings Snapshot (Associated Press)
04:30PM	Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance (Business Wire)
May-05-26 04:30PM	Phibro Animal Health Corporation Declares Quarterly Dividend (Business Wire)
04:15PM	Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership (Business Wire)
Apr-29-26 04:30PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results (Business Wire)
04:30PM	Loading…
Apr-27-26 04:30PM	Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials (Business Wire)
Mar-10-26 01:39PM	Stryker Introduces SmartHospital Platform to Advance Connected Care (Zacks)
01:11PM	GEHC Wins FDA 510(k) Approval for View, Enhances Radiology Workflows (Zacks)
Mar-09-26 01:50PM	Is Community Health Systems Attractive Despite Its Heavy Debt Load? (Zacks)
11:53AM	Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment (Zacks)
Mar-06-26 01:27PM	Here's Why Ensign Group Shares Are Attracting Investors Now (Zacks)
11:49AM	Here's Why You Should Add DaVita Stock to Your Portfolio for Now (Zacks)
11:44AM	BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease (Zacks)
09:38AM	Is This the Right Time to Retain IDXX Stock in Your Portfolio? (Zacks)
08:22AM	Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio? (Zacks)
Mar-05-26 01:00PM	Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates (Zacks)
12:46PM	BD Gains FDA Clearance for Surgiphor 1000mL Surgical Irrigation System (Zacks)
09:33AM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
08:52AM	Is This the Right Time to Add Globus Medical Stock to Your Portfolio? (Zacks)
Mar-04-26 12:30PM	Here's Why You Should Retain Clover Stock in Your Portfolio for Now (Zacks)
10:50AM	Loading…
10:50AM	Stryker Unveils Next-Gen Orthopedic Innovations at AAOS 2026 (Zacks)
08:14AM	Is This the Right Time to Hold Labcorp Stock in Your Portfolio? (Zacks)
Mar-01-26 05:06AM	Phibro Animal Health Raises Guidance at BofA Conference as Zoetis MFA Integration Advances (MarketBeat)
Feb-27-26 09:58AM	Zacks.com featured highlights include Crocs, LATAM Airlines, Arrow Electronics and Phibro Animal Health (Zacks)
Feb-26-26 02:00PM	4 Low-PEG Value Stocks for Smarter Portfolio Growth Today (Zacks)
Feb-23-26 08:00AM	Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks (Zacks)
Feb-20-26 10:00AM	Best Momentum Stocks to Buy for February 20th (Zacks)
07:19AM	Best Value Stocks to Buy for February 20th (Zacks)
07:18AM	New Strong Buy Stocks for February 20th (Zacks)
Feb-18-26 04:30PM	Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit (Business Wire)
04:09AM	Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion (Insider Monkey)
Feb-10-26 09:40AM	Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock (Zacks)
09:32AM	4 Discounted PEG Value Stocks to Boost Your Portfolio's Health (Zacks)
Feb-09-26 09:15AM	Why Phibro (PAHC) International Revenue Trends Deserve Your Attention (Zacks)
Feb-06-26 01:22PM	Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates (Zacks) +6.14%
12:45PM	3 Reasons Growth Investors Will Love Phibro (PAHC) (Zacks)
10:48AM	MCK Q3 Earnings & Sales Top Estimates, 2026 View Up (Zacks)
09:50AM	Phibro Animal Health (PAHC) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
09:15AM	Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue? (Zacks)
08:07AM	QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down (Zacks)
08:03AM	RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
Feb-05-26 11:37PM	Phibro Animal Health Q2 Earnings Call Highlights (MarketBeat) +21.95%
04:01PM	Phibro Animal Health Corp (PAHC) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
03:32PM	Stock Market Today: Dow, Nasdaq Struggle; Animal Health Name Soars (Live Coverage) (Investor's Business Daily)
10:27AM	CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains (Zacks)
Feb-04-26 07:30PM	Compared to Estimates, Phibro (PAHC) Q2 Earnings: A Look at Key Metrics (Zacks)
06:15PM	Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates (Zacks)
05:39PM	Phibro Animal Health (NASDAQ:PAHC) Misses Q2 CY2026 Revenue Estimates, But Stock Soars 5.5% (StockStory)
05:13PM	Phibro: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:25PM	Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance (Business Wire)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:03AM	GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls (Zacks)
Feb-03-26 04:10PM	Phibro Animal Health Corporation Declares Quarterly Dividend (Business Wire)
12:02PM	Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions (Zacks)
05:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Revised) (Zacks)
Feb-02-26 09:49AM	Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates (Zacks)
09:08AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
Jan-30-26 10:25AM	SYK Stock Gains as Q4 Earnings & Sales Beat on Strong Mako Adoption (Zacks)
09:45AM	Phibro Animal Health (PAHC) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Jan-29-26 08:32AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Jan-28-26 04:30PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results (Business Wire)
08:24AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
07:46AM	PAHC Q2 Earnings Preview: Animal Health Momentum Likely to Aid Results (Zacks)
Jan-26-26 11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? (Zacks)
Jan-23-26 09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks) -6.25%
Jan-22-26 08:40AM	Abbott (ABT) Matches Q4 Earnings Estimates (Zacks)
Jan-21-26 08:01AM	Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now (Zacks)
07:54AM	Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? (Zacks)
Jan-20-26 08:36AM	Should You Still Hold GMED Stock in Your Portfolio? (Zacks)
Jan-16-26 09:34AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Jan-15-26 12:09PM	CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 (Zacks)
09:42AM	Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It? (Zacks)
09:42AM	Is it Apt to Retain HAE Stock in Your Portfolio for Now? (Zacks)
09:36AM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
Jan-14-26 12:50PM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
12:00PM	Phibro (PAHC) Upgraded to Strong Buy: Here's Why (Zacks)
11:05AM	KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery (Zacks)
09:45AM	Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock (Zacks)
07:50AM	Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? (Zacks)
07:19AM	Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? (Zacks)
Jan-09-26 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC) (Zacks)
11:40AM	PAHC vs. BSX: Which Stock Should Value Investors Buy Now? (Zacks)
09:08AM	Is it the Right Time to Add STERIS Stock to Your Portfolio? (Zacks)
07:45AM	Tempus AI Stock Surges 82.4% in a Year: What's Driving It? (Zacks)
Jan-08-26 09:40AM	Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? (Zacks)
09:31AM	Zacks.com featured highlights include Animal Health, Commercial Metals, Fox and Adtalem Global Education (Zacks)
08:27AM	Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? (Zacks)
07:57AM	Is This the Right Time to Add Resmed Stock to Your Portfolio? (Zacks)
Jan-07-26 03:00PM	4 PEG-Based GARP Picks for Navigating Early-2026 Market Uncertainty (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BFI Co. LLC	10% Owner	Sep 16 '26	Proposed Sale	35.30	350,000	12,355,000		Sep 16 05:18 PM
Bendheim Daniel M	Officer	Aug 04 '26	Proposed Sale	36.60	486	17,787		Aug 04 03:52 PM
Escudero Lisa Ann	Officer	Aug 04 '26	Proposed Sale	36.60	265	9,699		Aug 04 03:34 PM
David Glenn	Officer	Aug 04 '26	Proposed Sale	36.60	840	30,744		Aug 04 03:32 PM
BENDHEIM JACK	Officer	Aug 04 '26	Proposed Sale	36.60	2,303	84,288		Aug 04 03:31 PM
Miller Larry Lee	Officer	Aug 04 '26	Proposed Sale	36.60	635	23,241		Aug 04 03:27 PM
Weinstein Judith	Officer	Aug 04 '26	Proposed Sale	36.60	472	17,275		Aug 04 03:22 PM
BFI Co. LLC	10% Owner	Jun 16 '26	Proposed Sale	31.87	281,600	8,974,592		Jun 16 06:04 PM
CORCORAN E THOMAS	Director	May 29 '26	Buy	31.77	10,000	317,700	41,459	Jun 02 06:56 PM
BENDHEIM JACK	President and CEO	May 06 '26	Sale	57.37	7,040	403,850	60,680	May 07 07:34 PM
BENDHEIM JACK	President and CEO	May 05 '26	Sale	55.80	7,040	392,810	67,720	May 07 07:34 PM
BENDHEIM JACK	President and CEO	May 07 '26	Sale	48.49	4,528	219,568	56,152	May 07 07:34 PM
BENDHEIM JACK	President and CEO	Apr 28 '26	Sale	55.91	7,040	393,575	88,840	Apr 30 07:20 PM
BENDHEIM JACK	President and CEO	Apr 29 '26	Sale	52.92	7,040	372,553	81,800	Apr 30 07:20 PM
BENDHEIM JACK	President and CEO	Apr 30 '26	Sale	52.76	7,040	371,465	74,760	Apr 30 07:20 PM
BENDHEIM JACK	President and CEO	Apr 21 '26	Sale	55.98	7,040	394,081	109,960	Apr 23 07:30 PM
BENDHEIM JACK	President and CEO	Apr 22 '26	Sale	54.29	7,040	382,185	102,920	Apr 23 07:30 PM
BENDHEIM JACK	President and CEO	Apr 23 '26	Sale	54.09	7,040	380,826	95,880	Apr 23 07:30 PM
BENDHEIM JACK	President and CEO	Apr 14 '26	Sale	59.08	7,040	415,922	31,080	Apr 16 08:25 PM
BENDHEIM JACK	President and CEO	Apr 15 '26	Sale	56.96	7,040	401,011	24,040	Apr 16 08:25 PM
BENDHEIM JACK	President and CEO	Apr 16 '26	Sale	54.64	7,040	384,662	117,000	Apr 16 08:25 PM
BENDHEIM JACK	President and CEO	Mar 31 '26	Sale	53.90	7,040	379,428	38,120	Mar 31 06:44 PM
BENDHEIM JACK	President and CEO	Mar 30 '26	Sale	53.61	7,040	377,406	45,160	Mar 31 06:44 PM
BENDHEIM JACK	President and CEO	Mar 26 '26	Sale	56.80	7,040	399,876	52,200	Mar 26 09:19 PM
BENDHEIM JACK	President and CEO	Mar 25 '26	Sale	55.91	7,040	393,606	59,240	Mar 26 09:19 PM
BENDHEIM JACK	President and CEO	Mar 24 '26	Sale	52.93	7,040	372,623	66,280	Mar 26 09:19 PM
BENDHEIM JACK	President and CEO	Mar 18 '26	Sale	52.68	10,560	556,330	80,360	Mar 19 07:58 PM
BENDHEIM JACK	President and CEO	Mar 19 '26	Sale	52.52	7,040	369,729	73,320	Mar 19 07:58 PM
BENDHEIM JACK	President and CEO	Mar 17 '26	Sale	51.66	5,280	272,760	90,920	Mar 19 07:58 PM
BENDHEIM JACK	President and CEO	Mar 13 '26	Sale	48.91	5,280	258,245	96,200	Mar 16 04:15 PM
BFI Co. LLC	10% Owner	Mar 13 '26	Proposed Sale	49.47	246,400	12,189,408		Mar 13 04:30 PM
BENDHEIM JACK	President and CEO	Feb 26 '26	Sale	53.73	7,040	378,266	1,480	Feb 26 07:09 PM
BENDHEIM JACK	President and CEO	Feb 25 '26	Sale	51.71	7,040	364,041	8,520	Feb 26 07:09 PM
BENDHEIM JACK	President and CEO	Feb 24 '26	Sale	51.37	7,040	361,630	15,560	Feb 26 07:09 PM
BENDHEIM JACK	President and CEO	Feb 20 '26	Sale	51.42	7,040	361,967	22,600	Feb 23 04:30 PM
BENDHEIM JACK	President and CEO	Feb 19 '26	Sale	50.26	7,040	353,808	29,640	Feb 23 04:30 PM
BENDHEIM JACK	President and CEO	Feb 13 '26	Sale	51.96	7,040	365,822	43,720	Feb 18 07:40 PM
BENDHEIM JACK	President and CEO	Feb 18 '26	Sale	51.40	7,040	361,825	36,680	Feb 18 07:40 PM
BENDHEIM JACK	President and CEO	Feb 10 '26	Sale	51.81	58,014	3,005,525	64,944	Feb 11 06:27 PM
BENDHEIM JACK	President and CEO	Feb 11 '26	Sale	51.62	14,184	732,186	50,760	Feb 11 06:27 PM
David Glenn	Officer	Feb 11 '26	Proposed Sale	51.62	12,528	646,758		Feb 11 11:51 AM
BENDHEIM JACK	President and CEO	Feb 05 '26	Sale	48.38	110,842	5,362,103	122,958	Feb 09 04:15 PM
BENDHEIM JACK	President and CEO	Feb 03 '26	Sale	41.47	9,660	400,610	22,320	Feb 05 07:22 PM
BENDHEIM JACK	President and CEO	Feb 04 '26	Sale	41.15	3,520	144,863	48,800	Feb 05 07:22 PM
BENDHEIM JACK	President and CEO	Jan 29 '26	Sale	40.12	6,772	271,687	38,673	Feb 02 04:15 PM
BENDHEIM JACK	President and CEO	Jan 30 '26	Sale	40.09	6,693	268,350	31,980	Feb 02 04:15 PM
BENDHEIM JACK	President and CEO	Jan 23 '26	Sale	40.55	1,235	50,084	15,445	Jan 27 04:15 PM
BENDHEIM JACK	President and CEO	Jan 21 '26	Sale	41.68	14,687	612,128	29,838	Jan 22 07:41 PM
BENDHEIM JACK	President and CEO	Jan 22 '26	Sale	41.98	13,158	552,420	18	Jan 22 07:41 PM
BENDHEIM JACK	President and CEO	Jan 13 '26	Sale	40.32	7,551	304,422	31,108	Jan 15 06:24 PM
BENDHEIM JACK	President and CEO	Jan 14 '26	Sale	40.53	3,651	147,983	47,457	Jan 15 06:24 PM
BENDHEIM JACK	President and CEO	Jan 15 '26	Sale	40.02	2,932	117,348	44,525	Jan 15 06:24 PM
BENDHEIM JACK	President and CEO	Jan 09 '26	Sale	40.16	213	8,554	38,659	Jan 13 06:53 PM
BENDHEIM JACK	President and CEO	Jan 07 '26	Sale	40.09	328	13,149	38,872	Jan 08 06:07 PM
BENDHEIM JACK	President and CEO	Dec 11 '25	Sale	40.93	5,752	235,405	39,200	Dec 15 04:51 PM
BENDHEIM JACK	President and CEO	Dec 08 '25	Sale	40.06	3,520	141,018	46,240	Dec 10 04:15 PM
BENDHEIM JACK	President and CEO	Dec 09 '25	Sale	40.19	1,288	51,763	44,952	Dec 10 04:15 PM
BENDHEIM JACK	President and CEO	Dec 04 '25	Sale	41.22	3,520	145,096	49,760	Dec 04 06:34 PM
BENDHEIM JACK	President and CEO	Dec 03 '25	Sale	40.77	3,520	143,511	53,280	Dec 04 06:34 PM
BFI Co. LLC	10% Owner	Dec 04 '25	Proposed Sale	40.77	316,800	12,915,936		Dec 04 05:07 PM
BENDHEIM JACK	President and CEO	Nov 28 '25	Sale	42.54	3,520	149,740	30,320	Dec 02 04:15 PM
BENDHEIM JACK	President and CEO	Dec 01 '25	Sale	41.66	3,520	146,636	26,800	Dec 02 04:15 PM
BENDHEIM JACK	President and CEO	Nov 25 '25	Sale	43.93	7,040	309,240	39,120	Nov 26 05:46 PM
BENDHEIM JACK	President and CEO	Nov 26 '25	Sale	44.02	5,280	232,434	33,840	Nov 26 05:46 PM
BENDHEIM JACK	President and CEO	Nov 20 '25	Sale	41.76	3,520	147,002	46,160	Nov 24 04:15 PM
BENDHEIM JACK	President and CEO	Nov 17 '25	Sale	44.56	5,280	235,254	54,960	Nov 18 07:50 PM
BENDHEIM JACK	President and CEO	Nov 18 '25	Sale	43.82	5,280	231,377	49,680	Nov 18 07:50 PM
BENDHEIM JACK	President and CEO	Nov 12 '25	Sale	45.23	21,536	973,976	14,041	Nov 13 08:24 PM
BENDHEIM JACK	President and CEO	Nov 13 '25	Sale	44.47	8,801	391,417	5,240	Nov 13 08:24 PM
BENDHEIM JACK	President and CEO	Nov 10 '25	Sale	45.29	38,303	1,734,767	20,577	Nov 10 07:50 PM
BENDHEIM JACK	President and CEO	Nov 07 '25	Sale	42.86	3,520	150,851	58,880	Nov 10 07:50 PM
BENDHEIM JACK	President and CEO	Nov 04 '25	Sale	43.10	3,520	151,703	65,920	Nov 06 05:46 PM
BENDHEIM JACK	President and CEO	Nov 05 '25	Sale	41.21	3,520	145,075	62,400	Nov 06 05:46 PM

Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment focuses on the development and marketing of medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment is involved in the manufacture and marketing of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Executive ChairmanMr. Jack Clifford Bendheim

CEOMr. Daniel M. Bendheim J.D.

Chief Financial OfficerMr. Glenn C. David

Chief Operating OfficerMr. Larry L. Miller

Senior VPMs. Judith A. Weinstein

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Phibro Animal Health Corp

Upgrade your Finviz experience